NanoZymeX’s cover photo
NanoZymeX

NanoZymeX

Pharmaceutical Manufacturing

We Develop Next Generation Enzyme Replacement Therapy for Lysosomal Storage Diseases

About us

NanoZymeX is developing a next-generation enzyme replacement therapy that significantly improves treatment efficacy while reducing immune-related side effects. Our approach addresses key limitations of current therapies, offering a more durable and better-tolerated solution for patients with lysosomal storage diseases and other enzyme deficiency disorders.

Website
www.nanozymex.com
Industry
Pharmaceutical Manufacturing
Company size
2-10 employees
Type
Privately Held

Employees at NanoZymeX

Updates

Similar pages